Diagnosis and treatment of infections due to mycobacterium avium complex

Seminars in Respiratory and Critical Care Medicine

Volumn 29, Issue 5, 2008, Pages 569-576

  Kasperbauer, Shannon H ^a   Daley, Charles L ^a  

^a DEPARTMENT OF MEDICINE   (United States)

Author keywords

Diagnosis; Mycobacterium avium complex; Nontuberculous mycobacteria; Treatment

Indexed keywords

AMIKACIN; ANTIMYCOBACTERIAL AGENT; AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; ETHAMBUTOL; GAMMA INTERFERON; GATIFLOXACIN; MACROLIDE; MOXIFLOXACIN; PLACEBO; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFABUTIN; RIFAMPICIN; RIFAMYCIN; STREPTOMYCIN;

ABSCESS; ALLERGIC PNEUMONITIS; ARTHRITIS; BACTERIAL INFECTION; BACTERIUM CONTAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DISSEMINATED BACTERIAL INFECTION; DRUG INTERMITTENT THERAPY; DRUG WITHDRAWAL; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG DISEASE; LUNG INFECTION; LYMPHADENITIS; MONOTHERAPY; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; NONHUMAN; OSTEOMYELITIS; PRIORITY JOURNAL; REVIEW; SKIN DEFECT; SPUTUM ANALYSIS; TENOSYNOVITIS; THORAX RADIOGRAPHY; TREATMENT DURATION;

ANTI-BACTERIAL AGENTS; ANTITUBERCULAR AGENTS; CLINICAL TRIALS AS TOPIC; DRUG THERAPY, COMBINATION; ETHAMBUTOL; HUMANS; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; RIFAMPIN;

EID: 53549104776     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0028-1085708     Document Type: Review

References (43)

1. Turenne CY, Wallace RJr, Behr MA. Mycobacterium avium in the postgenomic era. Clin Microbiol Rev 2007;20:205-229
2. Falkinham JO III. Nontuberculous mycobacteria in the environment. Clin Chest Med 2002;23:529-551
3. Marras TK, Daley CL. Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med 2002;23:553-567
4. Khan K, Wang J, Marras TK. Nontuberculous mycobacterial sensitization in the United States: national trends over three decades. Am J Respir Crit Care Med 2007;176:306-313
5. Marras TK, Chedore P, Ying AM, Jamieson F. Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997 2003. Thorax 2007;62:661-666
6. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175:367-416
7. Pasteur MC, Helliwell SM, Houghton SJ, et al. An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med 2000;162(4 Pt 1):1277-1284
8. Field SK, Fisher D, Cowie RL. Mycobacterium avium complex pulmonary disease in patients without HIV infection. Chest 2004;126:566-581
9. Dautzenberg B, Piperno D, Diot P, Truffot-Pernot C, Chauvin JP. Clarithromycin in the treatment of Mycobacterium avium lung infections in patients without AIDS. Clarithromycin Study Group of France. Chest 1995;107:1035-1040
10. Wallace RJ Jr, Brown BA, Griffith DE, et al. Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease. Am J Respir Crit Care Med 1994;149:1335-1341
11. Griffith DE, Brown BA, Girard WM. Murphy DT, Wallace RJ Jr. Azithromycin activity against Mycobacterium avium complex lung disease in patients who were not infected with human immunodeficiency virus. Clin Infect Dis 1996;23:983-989
12. Kobashi Y, Yoshida K, Miyashita N, Niki Y, Oka M. Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drugsensitivity testing of Mycobacterium avium complex isolates. J Infect Chemother 2006;12:195-202
13. Kobashi Y, Matsushima T. The microbiological and clinical effects of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease in Japan-including a follow-up study. Respiration 2007;74:394-400
14. Kuwabara K, Tsuchiya T. Clinical features and treatment history of clarithromycin resistance in M. avium-intracellulare complex pulmonary disease patients [in Japanese]. Nihon Kokyuki Gakkai Zasshi 2007;45(8):587-592
15. Griffith DE, Brown-Elliott BA, Langsjoen B, et al. Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2006;174:928-934
16. Kohno Y, Ohno H, Miyazaki Y, et al. In vitro and in vivo activities of novel fluoroquinolones alone and in combination with clarithromycin against clinically isolated Mycobacterium avium complex strains in Japan. Antimicrob Agents Chemother 2007;51:4071-4076 16a. Kasperbauer S, Wilson SE, Graham JJ, Heifets L, Daley C. Fluoroquinolone susceptibility in non-tuberculous mycobacteria. Presented at: The American Thoracic Society International Conference; May 23, 2007; San Francisco, CA: Abstract p. 971
17. Griffith DE, Brown BA, Girard WM, Griffith BE, Couch LA, Wallace RJ Jr. Azithromycin-containing regimens for treatment of Mycobacterium avium complex lung disease. Clin Infect Dis 2001;32:1547-1553
18. Griffith DE, Brown BA, Cegielski P, Murphy DT, Wallace RJ Jr. Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex. Clin Infect Dis 2000;30:288-292
19. Lam PK, Griffith DE, Aksamit TR, et al. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2006;173:1283-1289
20. Kobashi Y, Matsushima T, Oka M. A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease. Respir Med 2007;101:130-138
21. Jenkins PA, Campbell IA, Banks J, Gelder CM, Prescott RJ, Smith AP. Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy. Thorax 2008;63:627-634
22. Kuroishi S, Nakamura Y, Hayakawa H, et al. Mycobacterium avium complex disease: prognostic implication of highresolution computed tomography findings. Eur Respir J 2008;32:147-152
23. Horsburgh CR Jr. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med 1991;324:1332-1338
24. Chin DP, Hopewell PC, Yajko DM, et al. Mycobacterium avium complex in the respiratory or gastrointestinal tract and the risk of M. avium complex bacteremia in patients with human immunodeficiency vims infection. J Infect Dis 1994; 169:289-295
25. von Reyn CF, Maslow JN, Barber TW, Falkinham JO III, Arbeit RD. Persistent colonisation of potable water as a source of Mycobacterium avium infection in AIDS. Lancet 1994;343:1137-1141
26. Benson CA. Disease due to the Mycobacterium avium complex in patients with AIDS: epidemiology and clinical syndrome. Clin Infect Dis 1994;18(Suppl 3):S218-S222
27. Benson CA, Kaplan JE, Masur H, Pau A, Holmes KK. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. MMWR Recomm Rep 2004;53(RR-15):1-112
28. Benson CA, Williams PL, Currier JS, et al. A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndrome. Clin Infect Dis 2003;37:1234-1243
29. Gordin FM, Sullam PM, Shafran SD, et al. A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex. Clin Infect Dis 1999;28:1080-1085
30. Corti M, Villafane MF, Ambroggi M, Sawicki M, Gancedo E. Soft tissue abscess and lymphadenitis due to Mycobacterium avium complex as an expression of immune reconstitution inflammatory syndrome after a second scheme of highly active antiretroviral therapy. Rev Inst Med Trop Sao Paulo 2007;49:267-270
31. Phillips P, Bonner S, Gataric N, et al. Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term followup. Clin Infect Dis 2005;41:1483-1497
32. Shelburne SA III, Hamill RJ. The immune reconstitution inflammatory syndrome. AIDS Rev 2003;5:67-79
33. Salvana EM, Cooper GS, Salata RA. Mycobacterium other than tuberculosis (MOTT) infection: an emerging disease in infliximab-treated patients. J Infect 2007;55:484-487
34. Olsen RJ, Cernoch PL, Land GA. Mycobacterial synovitis caused by slow-growing nonchromogenic species: eighteen cases and a review of the literature. Arch Pathol Lab Med 2006;130:783-791
35. Hellinger WC, Smilack JD, Greider JL Jr, et al. Localized soft-tissue infections with Mycobacterium avium/Mycobacterium intracellulare complex in immunocompetent patients: granulomatous tenosynovitis of the hand or wrist. Clin Infect Dis 1995;21:65-69
36. Maltezou HC, Spyridis P, Kafetzis DA. Nontuberculous mycobacterial lymphadenitis in children. Pediatr Infect Dis J 1999;18:968-970
37. Liao CH, Lai CC, Ding LW, et al. Skin and soft tissue infection caused by non-tuberculous mycobacteria. Int J Tuberc Lung Dis 2007;11:96-102
38. Hanak V, Golbin JM, Ryu JH. Causes and presenting features in 85 consecutive patients with hypersensitivity pneumonitis. Mayo Clin Proc 2007;82:812-816
39. Marras TK, Wallace RJ Jr, Koth LL, Stulbarg MS, Cowl CT, Daley CL. Hypersensitivity pneumonitis reaction to Mycobacterium avium in household water. Chest 2005; 127:664-671
40. Hartman TE, Jensen E, Tazelaar HD, Hanak V, Ryu JH. CT findings of granulomatous pneumonitis secondary to Mycobacterium avium-intracellulare inhalation: "hot tub lung". AJR 2007;188:1050-1053
41. Hanak V, Kalra S, Aksamit TR, Hartman TE, Tazelaar HD, Ryu JH. Hot tub lung: presenting features and clinical course of 21 patients. Respir Med 2006;100:610-615
42. Centers for Diseases Control and Prevention. Respiratory illness in workers exposed to metalworking fluid contaminated with nontuberculous mycobacteria-Ohio, 2001. JAMA 2002; 287:3073-3074
43. Centers for Disease Control and Prevention (CDC). Respiratory illness in workers exposed to metalworking fluid contaminated with nontuberculous mycobacteria-Ohio, 2001. MMWR Morb Mortal Wkly Rep 2002;51:349-352